UPDATE: Jefferies Downgrades Vanda Pharmaceuticals (VNDA) to Hold
Tweet Send to a Friend
(Updated - February 25, 2022 8:35 AM EST)
Jefferies analyst Chris Howerton downgraded Vanda Pharmaceuticals (NASDAQ: VNDA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Chris Howerton downgraded Vanda Pharmaceuticals (NASDAQ: VNDA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
